Fidelity Investments’s Instil Bio TIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5
Closed -$94 5589
2025
Q3
$94 Hold
5
﹤0.01% 5206
2025
Q2
$110 Sell
5
-74
-94% -$1.55K ﹤0.01% 5132
2025
Q1
$1.37K Buy
+79
New +$1.64K ﹤0.01% 4931
2023
Q4
Sell
-3
Closed -$24 5644
2023
Q3
$24 Sell
3
-871
-100% -$8.78K ﹤0.01% 5064
2023
Q2
$9.63K Sell
874
-1,375
-61% -$16.8K ﹤0.01% 4158
2023
Q1
$29.7K Sell
2,249
-613,032
-100% -$9.06M ﹤0.01% 3667
2022
Q4
$7.75M Sell
615,281
-357,421
-37% -$17.7M ﹤0.01% 1988
2022
Q3
$94.2M Buy
972,702
+3,214
+0.3% +$368K 0.01% 979
2022
Q2
$89.6M Buy
969,488
+62,602
+7% +$8.87M 0.01% 1017
2022
Q1
$195M Buy
906,886
+162,124
+22% +$37.9M 0.02% 785
2021
Q4
$255M Buy
744,762
+121,915
+20% +$47.1M 0.02% 708
2021
Q3
$223M Buy
622,847
+84,929
+16% +$31.7M 0.02% 759
2021
Q2
$204M Buy
537,918
+180,699
+51% +$67M 0.02% 824
2021
Q1
$170M Buy
+357,219
New +$183M 0.01% 862

Other funds holding TIL

Fidelity Investments's TIL Position: Q4 2025 in Review

Fidelity Investments sold out of Instil Bio (TIL) in Q4 2025, closing a stake of 5 shares — an estimated $94 sold.

Fidelity Investments first reported a position in TIL in Q1 2021 and held it in 14 quarters. The position peaked at $255M in Q4 2021. 29 funds tracked by Wall St. Rank hold TIL as of Q4 2025.

  • Fidelity Investments reported no remaining Instil Bio position as of Q4 2025 after selling out during the quarter.
  • Fidelity Investments sold 5 Instil Bio shares in Q4 2025, an estimated $94.
  • Fidelity Investments first reported a position in Instil Bio in Q1 2021 and held it in 14 quarters.
  • Fidelity Investments's Instil Bio position peaked at $255M in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Instil Bio as of Q4 2025.

Based on Fidelity Investments's 13F filing for Q4 2025, filed 17 Feb 2026.